Discount cards for brand-name drugs provided to patients increased private insurer costs by 46% and varied in their impact on out-of-pocket payments by patients, found new research in the CMAJ.
Here we go again - it’s flu season! Let’s talk about some of the misperceptions out there that we’ll be dealing with more and more as the season gets into full swing.
The OMA argues that the legislation will allow the government to unilaterally amend and impose terms upon existing Alternate Payment Plan agreements after physicians have signed them